Tirzepatide 20

Tirzepatide 20 — 20mg Research Peptide Tirzepatide 20 contains 20mg of Tirzepatide, a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide is based on the native GIP sequence with modifications that enable dual receptor activation. Tirzepatide has been the subject of extensive clinical research programs (SURPASS and SURMOUNT trials) demonstrating significant effects on glycaemic control and body weight reduction. Its unique dual mechanism of action makes it a compound of exceptional interest in metabolic research. Key Research Areas: - Dual incretin receptor agonism (GIP/GLP-1) - Insulin secretion pathway studies - Glucose homeostasis research - Metabolic regulation investigations - Appetite and satiety signaling research - Pancreatic beta-cell function studies Composition per vial: Tirzepatide — 20mg Storage: Store at -20°C for long-term stability. Reconstituted solutions should be stored at 2-8°C. Handling: Follow appropriate laboratory handling procedures. Disclaimer: This product is intended for research purposes only. Not for human consumption.